Intravenous administration of hUCB-MSCs did not affect the density of CD68+ total macrophages but significantly increased macrophages expressing CD206, a marker of M2 macrophages, in RDEB skin at day 56 (Figure 5). This evidence concerns the gene CD68 and recessive dystrophic epidermolysis bullosa.